As announced on the USPTO website, as of June 30, 2012, there will be a daily limit of $49,999.99 for credit card accounts, but no daily limit for debit card accounts. (Currently, the daily limit for both credit card and debit card accounts is $99,999.99.) The new limit will be enforced automatically through the Pay.gov system, and any transaction that would exceed the limit will be rejected. Notably, the new cap may be too low for even a single Request for Inter Partes Review or Post Grant Review depending on the number of patent claims at issue.
(The USPTO also accepts payment by deposit account, electronic funds transfer (EFT) over the USPTO Website, and wire transfer through the Federal Reserve Fedwire System.)
Related Insights
December 2, 2025
PharmaPatents
Seeking Grace: Pursuing Method of Treatment Claims in View of Clinical Trial Related Disclosures
This article was originally published in the AIPLA Chemical Practice Chronicles Fall 2025 newsletter and is republished here with…
January 30, 2023
Blogs
USPTO-FDA Listening Session — Voices from Patient and Patent Advocates
On January 19, 2023, the U.S. Patent and Trademark Office (USPTO) and Food and Drug Administration (FDA) held a “listening session” focusing on USPTO-FDA collaboration initiatives proposed pursuant to President Biden's Executive Order on “Promoting Competition in the American Economy” to “promote greater access to medicines for American families.”
August 6, 2019
Blogs
USPTO Proposes Fee Hikes And New Fees
The USPTO has taken another major step in the fee-setting process for fee adjustments it expects to implement in January 2021, and published the proposed fees in the Federal Register. The major changes are the same as those originally proposed in August of 2018, and include two new fees that will impact all applicants and practitioners. As before, all fees not specifically targeted for adjustment will increase by about 5%. Public comments are due by September 30, 2019.